Crosslinked poly-γ-glutamic acid based nanosystem for drug delivery

被引:4
作者
Csikos, Zsuzsanna [1 ]
Fazekas, Erika [1 ]
Rozsa, David [1 ]
Borbely, Janos [2 ]
Kerekes, Krisztina [1 ,2 ]
机构
[1] BBS Nanotechnol Ltd, Boszormenyi Str 212-B, H-4032 Debrecen, Hungary
[2] Univ Debrecen, Nagyerdei Krt 94, H-4032 Debrecen, Hungary
关键词
Biopolymer; Crosslinking; Doxorubicin; Drug delivery; Folate-targeted; Nanoparticles; NANOPARTICLES; IMPACT; PACLITAXEL; NANOGELS; SYSTEM;
D O I
10.1016/j.jddst.2018.10.026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study describes a method for the preparation of targeted drug delivery nanosystem from a water-soluble, biodegradable polymer by crosslinking. The nanosystem consists of poly-gamma-glutamic acid as carrier, doxorubicin as active ingredient, and folic acid as targeting agent. Crosslinks were made between the monomer units of poly-gamma-glutamic acid using a short spacer, which coupled and compressed the polymer chains and formed nanoparticles. Folic acid was conjugated through poly(ethylene-glycol) directly to the polymer before crosslinking, and also to the surface of the prepared nanoparticles, thus an enhanced targeting effect was provided. The encapsulation of the active ingredient was done by trapping it between the crosslinks. Using appropriate reaction conditions, the thus formed nanosystem had an average size of 140-200 nm, slightly negative surface charge, and retained its stability for several months at 4 degrees C in aqueous medium. Pharmacokinetic studies demonstrated that greater amount of doxorubicin can reach the tumor tissue in case of nanoparticles compared to the free drug molecules. In vivo antitumor study revealed better inhibitory effect on tumor growth in the crosslinked nanoparticles-treated animals than those treated by free drug, and the overall survival was also better.
引用
收藏
页码:478 / 489
页数:12
相关论文
共 28 条
[21]   Structural and dynamical characterization of poly-gamma-glutamic acid-based cross-linked nanoparticles [J].
Radu, Judit Eva Fleischer ;
Novak, Levente ;
Hartmann, John F. ;
Beheshti, Neda ;
Kjoniksen, Anna-Lena ;
Nystrom, Bo ;
Borbely, Janos .
COLLOID AND POLYMER SCIENCE, 2008, 286 (04) :365-376
[22]  
Rahman AM, 2007, INT J NANOMED, V2, P567
[23]   A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics [J].
Steichen, Stephanie D. ;
Caldorera-Moore, Mary ;
Peppas, Nicholas A. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 48 (03) :416-427
[24]   Doxorubicin pathways: pharmacodynamics and adverse effects [J].
Thorn, Caroline F. ;
Oshiro, Connie ;
Marsh, Sharon ;
Hernandez-Boussard, Tina ;
McLeod, Howard ;
Klein, Teri E. ;
Altman, Russ B. .
PHARMACOGENETICS AND GENOMICS, 2011, 21 (07) :440-446
[25]  
Tomassetti A, 2003, CANCER RES, V63, P696
[26]  
Torchilin Vladimir P, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-00477-3_1
[27]   Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs [J].
Xu, Wei ;
Ling, Peixue ;
Zhang, Tianmin .
JOURNAL OF DRUG DELIVERY, 2013, 2013
[28]   A comparative study of linear, Y-shaped and linear-dendritic methoxy poly(ethylene glycol)-block-polyamidoamine-block-poly(L-glutamic acid) block copolymers for doxorubicin delivery in vitro and in vivo [J].
Zhang, Yu ;
Xiao, Chunsheng ;
Ding, Jianxun ;
Li, Mingqiang ;
Chen, Xin ;
Tang, Zhaohui ;
Zhuang, Xiuli ;
Chen, Xuesi .
ACTA BIOMATERIALIA, 2016, 40 :243-253